Paroxetine toxicity in a newborn after in utero exposure: clinical symptoms correlate with serum levels
- PMID: 16418684
- DOI: 10.1097/01.ftd.0000187971.95000.25
Paroxetine toxicity in a newborn after in utero exposure: clinical symptoms correlate with serum levels
Abstract
There are several case reports and case series that have examined the acute effects of selective serotonin reuptake inhibitors (SSRIs) on the newborn. There is considerable controversy whether the reported symptoms represent withdrawal from the SSRI or toxicity caused by the SSRI. A case of an infant who was exposed to paroxetine during pregnancy is presented. This case supports the notion of serotonin toxicity and is believed to be the first report that substantiates clinical symptoms with serum levels of the offending SSRI.
Comment in
-
A new indication for therapeutic drug monitoring in the neonate.Ther Drug Monit. 2006 Feb;28(1):1. doi: 10.1097/01.ftd.0000187973.02624.67. Ther Drug Monit. 2006. PMID: 16418682 No abstract available.
-
Clinical relevance of TDM of SSRIs.Ther Drug Monit. 2006 Oct;28(5):716-7; author reply 717. doi: 10.1097/01.ftd.0000245378.87563.72. Ther Drug Monit. 2006. PMID: 17038895 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
